Literature DB >> 35862686

Sensing Host Health: Insights from Sensory Protein Signature of the Metagenome.

Subhrajit Bhar1, Rashmi Singh1, Nishal Kumar Pinna1, Tungadri Bose1, Anirban Dutta1, Sharmila S Mande1.   

Abstract

The human microbiota, which comprises an ensemble of taxonomically and functionally diverse but often mutually cooperating microorganisms, benefits its host by shaping the host immunity, energy harvesting, and digestion of complex carbohydrates as well as production of essential nutrients. Dysbiosis in the human microbiota, especially the gut microbiota, has been reported to be linked to several diseases and metabolic disorders. Recent studies have further indicated that tracking these dysbiotic variations could potentially be exploited as biomarkers of disease states. However, the human microbiota is not geography agnostic, and hence a taxonomy-based (microbiome) biomarker for disease diagnostics has certain limitations. In comparison, (microbiome) function-based biomarkers are expected to have a wider applicability. Given that (i) the host physiology undergoes certain changes in the course of a disease and (ii) host-associated microbial communities need to adapt to this changing microenvironment of their host, we hypothesized that signatures emanating from the abundance of bacterial proteins associated with the signal transduction system (herein referred to as sensory proteins [SPs]) might be able to distinguish between healthy and diseased states. To test this hypothesis, publicly available metagenomic data sets corresponding to three diverse health conditions, namely, colorectal cancer, type 2 diabetes mellitus, and schizophrenia, were analyzed. Results demonstrated that SP signatures (derived from host-associated metagenomic samples) indeed differentiated among healthy individual and patients suffering from diseases of various severities. Our finding was suggestive of the prospect of using SP signatures as early biomarkers for diagnosing the onset and progression of multiple diseases and metabolic disorders. IMPORTANCE The composition of the human microbiota, a collection of host-associated microbes, has been shown to differ among healthy and diseased individuals. Recent studies have investigated whether tracking these variations could be exploited for disease diagnostics. It has been noted that compared to microbial taxonomies, the ensemble of functional proteins encoded by microbial genes are less likely to be affected by changes in ethnicity and dietary preferences. These functions are expected to help the microbe adapt to changing environmental conditions. Thus, healthy individuals might harbor a different set of genes than diseased individuals. To test this hypothesis, we analyzed metagenomes from healthy and diseased individuals for signatures of a particular group of proteins called sensory proteins (SP), which enable the bacteria to sense and react to changes in their microenvironment. Results demonstrated that SP signatures indeed differentiate among healthy individuals and those suffering from diseases of various severities.

Entities:  

Keywords:  biomarker; disease diagnostics; machine learning; metagenome; sensory protein

Mesh:

Substances:

Year:  2022        PMID: 35862686      PMCID: PMC9361814          DOI: 10.1128/aem.00596-22

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   5.005


  50 in total

1.  One-component systems dominate signal transduction in prokaryotes.

Authors:  Luke E Ulrich; Eugene V Koonin; Igor B Zhulin
Journal:  Trends Microbiol       Date:  2005-02       Impact factor: 17.079

2.  Systematic mapping of two component response regulators to gene targets in a model sulfate reducing bacterium.

Authors:  Lara Rajeev; Eric G Luning; Paramvir S Dehal; Morgan N Price; Adam P Arkin; Aindrila Mukhopadhyay
Journal:  Genome Biol       Date:  2011-10-12       Impact factor: 13.583

3.  Dysbiosis of the gut microbiota in disease.

Authors:  Simon Carding; Kristin Verbeke; Daniel T Vipond; Bernard M Corfe; Lauren J Owen
Journal:  Microb Ecol Health Dis       Date:  2015-02-02

4.  Computational Analysis of Host-Pathogen Protein Interactions between Humans and Different Strains of Enterohemorrhagic Escherichia coli.

Authors:  Tungadri Bose; K V Venkatesh; Sharmila S Mande
Journal:  Front Cell Infect Microbiol       Date:  2017-04-19       Impact factor: 5.293

5.  The human gut Firmicute Roseburia intestinalis is a primary degrader of dietary β-mannans.

Authors:  Sabina Leanti La Rosa; Maria Louise Leth; Leszek Michalak; Morten Ejby Hansen; Nicholas A Pudlo; Robert Glowacki; Gabriel Pereira; Christopher T Workman; Magnus Ø Arntzen; Phillip B Pope; Eric C Martens; Maher Abou Hachem; Bjørge Westereng
Journal:  Nat Commun       Date:  2019-02-22       Impact factor: 14.919

Review 6.  Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.

Authors:  Daniela Parada Venegas; Marjorie K De la Fuente; Glauben Landskron; María Julieta González; Rodrigo Quera; Gerard Dijkstra; Hermie J M Harmsen; Klaas Nico Faber; Marcela A Hermoso
Journal:  Front Immunol       Date:  2019-03-11       Impact factor: 7.561

Review 7.  Hydrogen sulfide regulates insulin secretion and insulin resistance in diabetes mellitus, a new promising target for diabetes mellitus treatment? A review.

Authors:  Heng Zhang; Yaqian Huang; Selena Chen; Chaoshu Tang; Guang Wang; Junbao Du; Hongfang Jin
Journal:  J Adv Res       Date:  2020-02-26       Impact factor: 10.479

8.  Alterations of oral microbiota distinguish children with autism spectrum disorders from healthy controls.

Authors:  Yanan Qiao; Mingtao Wu; Yanhuizhi Feng; Zhichong Zhou; Lei Chen; Fengshan Chen
Journal:  Sci Rep       Date:  2018-01-25       Impact factor: 4.379

9.  The role of the microbiome for human health: from basic science to clinical applications.

Authors:  M Hasan Mohajeri; Robert J M Brummer; Robert A Rastall; Rinse K Weersma; Hermie J M Harmsen; Marijke Faas; Manfred Eggersdorfer
Journal:  Eur J Nutr       Date:  2018-05       Impact factor: 5.614

Review 10.  The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical Applications.

Authors:  Tomasz Szeligowski; Alexandra Lim Yun; Belinda R Lennox; Philip W J Burnet
Journal:  Front Psychiatry       Date:  2020-03-12       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.